Introduction
Genome-wide association studies (GWASs) using polymorphic nucleotide markers have as their main goal the identi¯cation of new genetic factors conferring individual susceptibility to complex diseases. Case/control studies may yield in°ated false positives due to population strati¯cation and admixture. Moreover, haplotype reconstruction can be inaccurately inferred because there are not familial genotypes. Therefore, tests using more than one marker usually are based on genotypes 1À3 instead of haplotypes, and power may also be reduced as well. To overcome this issue, we use an alternative group of tests, which require nuclear families and compare di®erences in transmitted and non-transmitted haplotype counts from parents to a®ected o®spring. The simplest test of this group, the Transmission/ Disequilibrium Test (TDT), 4 is de¯ned for a binary marker and considers that under the null hypothesis of no association or linkage, the only di®erence in the number of times an allele is transmitted or not should be due to random sampling. Therefore, the statistic is de¯ned for heterozygous parents as:
with n T being the number of times one of the alleles is transmitted by a parent to the o®spring and n U the number of times it is not transmitted (i.e. the parent transmits the other allele). The statistic follows a 2 distribution with one degree of freedom (df) under the null hypothesis of no association or linkage. TDT-based GWASs using only one marker at a time have revealed to be a very powerful approach to discover new genetic factors related to a trait when they are in allelic association À À À linkage disequilibrium À À À with an underlying risk allele (as long as it has a high relative risk to the trait). However, most complex diseases are polygenic traits which appear as a consequence of the interaction of several, maybe thousand, genetic variants, most of them with modest or very small e®ects, as well as the environment. This is the case of multiple sclerosis (MS) 5 or diabetes type 2. 6 In this situation, the basic TDT [Eq. (1)] has not enough power to detect those genetic factors with small relative risk, as it is a monomarker test. Di®erent generalizations have been proposed to handle more than two markers and improve power.
7À11
Perhaps the most intuitive multimarker generalization of TDT is mTDT 7, 8 :
with k being the number of di®erent alleles/haplotypes and n iT , n iU being, respectively, the number of times an allele/haplotype i is transmitted and nontransmitted, considering only heterozygous parental genotypes. The measure has a limiting 2 with k À 1 df ( 2 kÀ1 ) under no linkage. 19 However, the recent explosion of GWASs that are being performed has revealed an important problem in multimarker association tests: a high di±culty to reproduce results when a di®erent data set is used. 11 The problem intensi¯es with the number of markers tested at a time and makes most of multimarker association tests useless for more than two or three markers. This is a very discouraging result for the use of multimarker tests, even if it is well known that power increases with them. The main cause of this lack of test reliability is that they are built on methods that de¯ne an alternative hypotheses that is sample dependent, so that power is overestimated, a problem known as sample over¯tting in the Machine Learning¯eld. In this situation only very large samples would yield reliable results.
Solutions based on the distribution estimation of the results may be inaccurate. Therefore, those performing a uniform correction of p-values as a function of the total number of hypothesis, such as the the Bonferroni correction, perform an overcorrection, yielding very low power tests. As an example, the number of di®erent tests in the simple TDT applied using binary markers is 2 m , with m being the number of biallelic markers. Other less-strict corrections such as the stepwise procedures 12 consider the outcome of all the tests and not only the number of tests to reject an hypothesis. Thus, they compute a corrected p-value considering all raw p-values. However, they may be poorly applied i.e. the number of hypothesis is underestimated, as when the overall hypothesis is tested by evaluating a complex structure of many other hypothesis, 13 so that false positive results due to sample over¯tting will translate into a lack of test reproducibility when a di®erent data set is used. 14 A simple approach to overcome the issue of sample over¯tting is to use multiple sampling to assess statistical signi¯cance. Therefore, in its simplest modality, called holdout, in which the data set is split into two parts, one to build the model/ hypothesis and the other to compute the statistic, the test has the same df than when using another approach but only half of the data set. Although power will decrease due to a reduction in the sample size used to compute the statistic, the model built using half of the sample will¯t to the other half only in the case of true association, as data used to build a model (for mTDT the model is de¯ned just with a set of haplotypes present in a data set), are never used to test it. 15 Therefore, this approach is simple and provides a highly reproducible solution, as associations found are mostly due to real associations and not to false positive results because of multiple testing.
Another problem of many multimarker tests such as mTDT [Eq. (2)], mTDT S 8,16 À À À a score-based method that modi¯es mTDT to follow an exact 2 kÀ1 distribution under the null À À À or other tests alike, is that df increases with the number of markers, so that their power is downwardly a®ected. 9,11 A common solution is to group haplotypes based on di®erent criteria, such as ancestral proximity of haplotypes 17 or haplotype similarity. 9, 13, 14, 18 Reduction in df is led to its maximum when they do not change with the number of markers. This is the approach of TDT 1 , 19 a 2 1 multimarker test which checks di®erences in transmissions between the haplotype with the largest di®erences and the rest of haplotypes. The test is very powerful in the case of no mutation occurring from the non-recombinant haplotype with the disease variant. Another 2 1 test regardless the number of markers, 2G, 15 improves power of TDT 1 by removing the assumption that the non-recombinant haplotype has never mutated. Therefore, instead of building a null hypothesis of no association for one risk haplotype, it tests the hypothesis of no association for the set of all risk haplotypes. 2G outperforms TDT 1 because it allows more complex models while keeping the same df as TDT 1 . The model may represent multiple founders for a risk variant and more than one risk variant descending from the founder haplotype because of mutation/recombination. Similar ideas have been proposed for case/control or discordant-sib-pair studies but members of a risk group are in those studies not composed of haplotypes but of genotypes.
1À3
Although 2G outperforms TDT 1 in power, low frequent haplotypes are highly unreliable and may reduce power. If several markers are used at a time, to disregard low frequent haplotypes is not a choice, as many haplotypes have very low counts. Thereby we would end up with very few data and thus a signi¯cant power reduction, close to the power of TDT 1 , as the most recent mutations/recombinations from a high-risk haplotype (which usually have very low counts) that are still in association with the disease will be disregarded because of their low counts.
In this work we propose to use a method, 2GTree, which modi¯es 2G by using the most reliable haplotypes to be classi¯ed as low-and high-risk haplotypes as prior information to compute the probability of the more ambiguous haplotypes to be high/low-risk ones. We assume that haplotype similarity (which at its maximum is called identity by state, IBS) means genetic similarity (which at its maximum is called identity by descend, IBD) so that given a haplotype i the most similar haplotype to it, j, is the one with the shortest time to their most recent common ancestor (MRCA): t MRCA ði; jÞ < t MRCA ði; j 0 Þ8j 0 2 f1; . . . ; n; j 0 6 ¼ i; j 0 6 ¼ jg and therefore it has a higher probability of being also a non-recombinant haplotype with the trait variant if j is considered to be a non-recombinant haplotype with the trait variant (a high-risk haplotype). Consequently, it favors models in which haplotype trees built on them show a low entropy i.e. haplotype branches are mostly composed of haplotypes belonging to the same low/high-risk group.
In Sec. 2 we give a detailed de¯nition of the algorithm 2GTree and describe the data, simulated and real ones, used to test the algorithm. We show results in Sec. 3. Conclusions are provided in Sec. 4.
Methods
Before describing 2GTree, we¯rst describe 2G, as our proposal, 2GTree, is a modi¯cation of it.
Overview of 2G
As the number of di®erent haplotypes exponentially increases with the number of markers while sample sizes do not increase accordingly, 2G tries to keep power by collapsing haplotypes. Therefore, 2G always divides a data set into two groups: highrisk haplotypes (g 1 ) and low-risk haplotypes (g 2 ). For the test to be highly powerful, neither homozygous parents or those parents with both haplotypes in the same group are used. Consequently, haplotypes in the same group are being considered equivalent since the test relies on the strong assumption of all haplotypes in a group having similar Relative Risk, RR ¼ 1À for group g 1 , and
for group g 2 , and being the probability for a parental genotype with one haplotype in each group of transmitting the haplotype in g 1 to the o®spring. Under the null hypothesis of no association or linkage, RR is 1, so that is 0:5 in both groups.
There may be two possible explanations for having more than one high-risk haplotype. One is that all high-risk haplotypes share a common ancestor that mutated or was in linkage disequilibrium with a mutation associated with the trait under study. The other is that there may be more than one mutation at a genetic locus in association with a disease from which current haplotypes may have derived from, a situation known as founder heterogeneity. 20 Even if the assumption of same relative risks may not be true in most of the populations, its simplicity compensates the accuracy of the assumption. Thereby it causes the test to especially outperform the other tests whenever the length of the haplotypes increases. Thus, while most of the tests increase model complexity (df) with the haplotype length and become powerless because of a limited sample size, 2G has a constant model complexity (df) regardless of the haplotype length.
Given groups g 1 and g 2 have been made up, the statistic is de¯ned as:
with n g ¼ n g 1 g 2 þ n g 2 g 1 being the total amount of parental heterozygous genotypes with one haplotype in each group. The test is a McNemar test following a 2 1 distribution under the null hypothesis of no linkage or association. 15 Among the
di®erent ways to make up groups g 1 and g 2 from a set of k di®erent haplotypes, it is straightforward to show which is the solution achieving the largest power. In fact, this solution de¯nes the groups by considering as high-risk haplotypes (g 1 ) those with more transmitted haplotypes in the population i.e.
i > 1=2, and as low-risk haplotypes (g 2 ) those with more non-transmitted haplotypes in the population i.e. i < 1=2, with i being the probability for a haplotype h i of being transmitted. 2G uses this criterion:
and estimates i by using the maximum likelihood estimator (MLE) i ¼ n iT n iT þn iU .
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To avoid the problem of sample over¯tting, which increases with k, 2G uses the holdout approach. Thus, a data subset used to choose the best hypothesis, the training data set does not share any genotype with the data subset used to assess statistical signi¯cance, the test data set.
The number k of di®erent haplotypes exponentially increases with the number of markers. Therefore, for the test to be applied on a window of a few markers, many haplotypes in the test data set will not be found in groups g 1 or g 2 . In this situation, a group will be assigned to a haplotype h i by using the following criterion:
with s M ðh i ; g x Þ; x 2 f1; 2g being de¯ned as the similarity between h i and the haplotype in g x most similar to h i . In the case of same similarity to both groups, a group is randomly chosen. As similarity measure, 2G uses the length measure, 9, 13 which equals the largest number of consecutive markers with matching alleles and which is also used in mTDT LC and mTDT SR . 9 As an example for 4-snp-long haplotypes of biallelic markers 1010 and 1111, the length measure is 1, as the largest strand of matching alleles has size 1. Thus, there are two strands of size 1: the one with only the¯rst allele (1) and the one with only the third allele (1). In a second example, the length measure between haplotypes 1101 and 1111 is 2, as there is only one strand of size 2 composed of the two former alleles: 10.
2GTree
In this section we introduce 2GTree, a Bayesian modi¯cation of 2G which, in order to compute the probability of a haplotype of being a high-risk one, it considers as prior knowledge how similar it is to other high-risk haplotypes. 2GTree assumes IBS means IBD as prior knowledge. In general, to obtain prior knowledge, it assumes that haplotype similarity implies genetic linkage.
Under the null hypothesis of no association or linkage, the random variable X ij representing the number of times a heterozygous parent with haplotypes fh i ; h j g transmits h i to their o®spring, follows a binomial distribution with parameters ðN ij ; 1=2Þ, with N ij being the number of heterozigotic parents with haplotypes fh i ; h j g in the sample. Therefore, since X ij and X ik are independent for any k 6 ¼ j, X i ¼ P j6 ¼i X ij is binomial with parameters ðN i ; i Þ, being N i ¼ P j6 ¼i N ij and i ¼ 1=2. Therefore, every situation with i 6 ¼ 1=2 for any X i means an alternative hypothesis of association or linkage holds. Most of the multimarker TDTs, including mTDT and 2G, use the fact that for large samples, 2X i is normal with mean and variance N i and thus the square root of Y i ,
is standard normal and Y i is 2 1 .
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Our intention is to use a Bayesian approach to estimate i in the training sample as the expectation of i with respect to the posterior probabilities:
with D being the data set, so that h i will be assigned to a group by using the same criterion as 2G [see Eq. (4)] but a Bayesian estimator i of i . As X i is a binomial distribution with parameters ðN i ; i Þ, we can assume the prior distribution for i is a Betað 1 ; 2 Þ distribution 21 which will have 1 ¼ 2 in the case we believe the null hypothesis is true. Thereby, the larger the di®erence between 1 and 2 , the larger the prior knowledge against the null hypothesis.
To obtain the hyperparameters 1 ; 2 for the Beta distribution, 2GTree uses information about haplotype similarities assuming the coalescence model with no recombination 22 since only a small number of consecutive markers are used. 23 Therefore it assumes all haplotypes descend from a common ancestor without recombination and they make up a haplotype tree, which have haplotypes at its nodes. A haplotype tree can be seen in Fig. 1 . Similarity between haplotypes translates into a shorter distance between their respective nodes in the haplotype tree.
In the case of haplotypes with no di®erences in transmissions, the prior has a large e®ect and the haplotype will be assigned to the group to which the most similar haplotype belongs to. When di®erences increase, the prior decreases its e®ect on the posterior probability of a haplotype to be a low or a high-risk haplotype.
2GTree¯rst sorts all di®erent haplotypes h i ; i ¼ 1 . . . k by descending e®ect di®erence eðh i Þ in a training data set, measured as:
and for each haplotype h i following this ordering criterion, it applies Eq. (4) to decide the group it belongs to. To make this decision, it estimates i by using its Bayesian estimator i [Eq. (7)] instead of the MLE i used by 2G. The purpose of sorting haplotypes by descending e®ect di®erence is to start by those haplotypes with less uncertainty about to which group they belong to. Thus, there will be more chances of a right decision at the former haplotypes and therefore, this information, which is used as a prior for the remaining haplotypes, will also increase chances of a right decision in the following haplotypes. Hyperparameters i1 and i2 are chosen for each haplotype by considering the current composition of groups g 1 and g 2 and by using the following rule:
& with jg x j; x ¼ 1; 2 being the number of haplotypes in group g x , r i ¼ n 1 ðh i Þ n 1 ðh i Þþn 2 ðh i Þ and n x ðh i Þ; x 2 f1; 2g being de¯ned as the number of haplotypes in group g x with the maximum similarity to h i among all the haplotypes in g 1 [ g 2 :
n j ¼ n jT þ n jU and simða; bÞ being the similarity between haplotypes a and b. The intuition is to consider a largest prior probability to the group with a largest number of haplotypes with minimum distance to the one we are considering. r i represents the proportion of haplotypes in group g 1 . Therefore, both groups will have the same prior probability (r i ¼ 0:5; i1 ¼ i2 ) if both groups have the same number of haplotypes with minimal distance. In the extreme i.e. when there are no haplotypes in a group with minimal distance, r
. . . ; k has been set to 2. 21 The hyperparameter , sometimes called \precision," can be regarded as an equivalent sample size for the prior knowledge. 21 We chose it to be 2 so that a wrong prior will have a small e®ect in the¯nal power unless the sample size is really small. We considered di®erent sample sizes in our experiments from 125 trios to 1000 and even with the shortest data sets a wrong prior translated into very slight power decay of 2GTree compared with 2G (data not shown). In the case of at least a group being empty, a Betað1; 1Þ will be assumed so that every parameter in the likelihood distribution pðD j Þ % BinðN i ; Þ will have the same prior probability. Figure 2 shows the Beta distributions used when: (1) s M ðh i ; g 1 Þ > s M ðh i ; g 2 Þ: Betað1:5; 0:5Þ (top plots) so that there are larger prior support for haplotype h i to belong to group g 1 , (2) there are no haplotypes in at least one of the groups: Betað1; 1Þ (left middle plot) so that there are not any prior knowledge about the probability of haplotype h i to belong to a group (uniform distribution) and (3) s M ðh i ; g 2 Þ > s M ðh i ; g 1 Þ: Betað0:5; 1:5Þ (remaining plots) so that there are larger prior support for haplotype h i to belong to group g 2 .
As the Betað i1 ; i2 Þ distribution is the conjugate of the binomial distribution Binðn 1 ðh i Þ; Þ, the posterior probability is a Betað i1 þ n 1 ðh i Þ; i2 þ n 2 ðh i ÞÞ distribution and the Bayesian estimate of i computed as the expectation of i : i [Eq. (7)] has a close form solution 21 :
Equations (4) and (9) are applied by 2GTree for all the haplotypes so that at each step a new haplotype will be added to a group. Table 1 shows the grouping strategy of 2GTree in pseudocode. For each haplotype window i ¼ 1; . . . ; m, 2GTree requires to loop over the 2n haplotypes in the sample to compute n iT and n iU , the starting point of its grouping strategy (see Table 1 ), as well as 2G, mTDT , mTDT S and TDT 1 do. To group haplotypes, it requires also to loop over the k di®erent haplotypes found (it has to be noted that k < < n even for haplotype windows of several markers due to linkage disequilibrium) in order to compute eðh i Þ, a measure required as well as input data by the grouping strategy. The¯rst step in the grouping strategy (sorting haplotypes by eðh i Þ) is known to be Oðk log kÞ by the quicksort algorithm. The third and last time-consuming step requires to compute the length measure among all haplotypes already assigned to a group, so that s Â kðk À 1Þ=2 operations, s being a constant (window size), will be performed. Therefore, 2GTree will have as time complexity upper bound Oðmðn þ k 2 ÞÞ, the same as mTDT S or, if we take into account k < < n, we just have simply OðmnÞ as the upper bound for 2G, 2GTree, mTDT , mTDT S and TDT 1 algorithms. Table 2 shows an example of an input array built from all the heterozygous parents of a training data subset arti¯cially generated. The second column shows the transmission counts of each di®erent haplotype h i in the training data set, the third column shows the non-transmission counts and the four column shows the e®ect di®erence eðh i Þ. Table 3 sorts Table 2 by descending e®ect di®erence (fourth column) and add other columns with results that were required by the grouping strategy of 2GTree: n iT þ n iU (column 5), closest haplotypes in current g 1 (column 6), closest haplotypes in current g 2 (column 7), s M ðh i ; g 1 Þ (column 8), s M ðh i ; g 2 Þ (column 9), r i Fig. 2 . Di®erent Beta ð 1 ; 2 Þ distributions, 1 þ 2 ¼ 2. Left column from top to bottom: 1 values are 1:5; 1 and 0:5. 1 ¼ 1 is used when there is no prior knowledge about the group a haplotype should belong to. 1 ¼ 1:5 and 1 ¼ 0:5 is used when a haplotype is a priori considered as belonging to group g 1 , g 2 , respectively, because of similarity. Right column from top to bottom: 1 values are 1:4; 0:8 and 0:6. The larger the di®erence j 1 À 2 j, the larger the prior evidence for the haplotype to belong to the group g x ; x 2 f1; 2g with the greatest x . Table 3 . An extension of the example in Table 2 with partial and¯nal results derived when applying algorithm in Table 1 . (column 10), i1 (column 11), i2 (column 12), i (column 13) and the¯nal group the haplotype belongs to (column 14). The haplotype tree which summarizes the steps conducted by 2GTree to build the groups is shown in Fig. 1 . The most frequent haplotype h i with i 6 ¼ 0 is considered the root of the tree, and is the¯rst haplotype added to a group. The haplotype with largest similarity (largest length measure) is considered the closest ancestor of a haplotype. In case of a tie, the haplotype in the same group is chosen. If all the most similar haplotypes are in the other group, the most frequent haplotype is chosen.
Once groups g 1 and g 2 have been made up with the training data set, 2GTree has no di®erences with 2G in the way the test is computed by using the test data set. 15 Therefore, each haplotype h i in the test data set is assigned to a group by computing the function gðh i Þ and the statistic in Eq. (3).
Simulation studies
We have drawn haplotype samples of 500 familial trios under di®erent standard con¯gurations to check type-I errors under strati¯ed and admixture populations and power. 9, 18 In general, it means di®erent haplotype lengths and di®erent frequencies of common allele variants. For testing type-I errors, it means two strati¯ed populations with di®erent proportions among them (1=2; 1=4 and 1=6Þ and di®erent minor allele frequencies for one of the two subpopulations (0:1; 0:3 and 0:5) and 0:5 always for the other. For testing power, it means we considered scenarios with one and two disease susceptibility loci under di®erent genetic models (additive, recessive and dominant for one locus; additive, recessive-or-recessive, dominant-or-dominant, dominant-anddominant, threshold and modi¯ed for two loci).
However, we introduced several di®erences. 11, 15 For both studies (population strati¯cation/admixture and power) we considered a wide range of haplotype lengths, 1; 2; 5; 10; 15 and 20. The studies above referred 9, 18 only used one or two markers or sometimes three but as it has been said, the problem of model over¯tting increases with the number of markers. Moreover, in the power study, we reduced relative risks to more realistic values 1:2; 1:6; 2:0; 2:4 and 2:6. Populations were generated assuming the now standard coalescent approach. 22 The power study was enlarged by a locus-speci¯city study so that instead of testing a set of markers at one of the disease susceptibility locus (recombination fraction ¼ 0) we also considered an increase in ¼ 0:00005; 0:0001; 0:00015; 0:0002, in the way used in other works. 10, 11 To increase sample reproducibility, all the tests were applied under the holdout approach, in which for each data set, 250 trios were randomly chosen to learn the model (the training data set) and 125 were randomly chosen to assess statistical signi¯cance i.e. to obtain p-values (the test data set). The same length measure 9, 13 was used in all of them in order to assign haplotypes in the test data set to the models learned with the training data set. 15 A detailed description of the way simulations were performed can be seen at the supplementary website.
Real data
To test power, we have chosen nine di®erent risk loci in which SNPs in association with a complex disease or in strong linkage disequilibrium have been reported, one of them related with Crohn disease 24 and the others with MS. 26 The Crohn data set (Crohn-a®ected) is a publicly available set that was originally used in 2001. 25 It consists of the genotype data of 103 SNPs typed in 129 trios with o®spring having Crohn's disease. 24 The phenotype is the presence/absence of Crohn disease. The SNPs span across 500 kilobases at the IBD5/SLC22A4 locus (5q31), and the region contains 11 known genes. For MS disease, genotype information was obtained from a GWAS performed by the International Multiple Sclerosis Genetic Consortium with 334,923 SNPs in 931 family trios with a®ected o®spring. 26 To test speci¯city, we need data sets with all the family members being unaffected. To do that, we have used the same nine risk loci but family trios and their genotypes were obtained from the 30 Caucasian nuclear families (CEPH) used at Phase II of the International HapMap Project (IHMP). 27 For comparative purposes, and considering that di®erent arrays were used for genetic sequencing in the data sets with a®ected o®spring and in the IHMP data sets, we followed a procedure which mainly selected those markers present in both a®ected-o®spring and IHMP data sets used for each risk loci. 15 To reconstruct haplotypes from genotypes required to apply TDT or any of its generalizations, we used the common family-plus-E-M strategy, 9, 18, 28 in which family information is¯rst used and, in those loci still unsolved, the E-M algorithm is used. Phasing errors are very unusual when using this method, as most positions are inferred without errors by using familial data.
To guarantee sample reproducibility, all the tests were applied under the holdout approach, in which for each data set, half of the trios were randomly chosen to learn the model (the training data set) and the other half were used to assess statistical signi¯cance i.e. to obtain p-values (the test data set).
Results
We have compared 2GTree with some state-of-the-art multimarker TDTs: mTDT , mTDT S À À À a score modi¯cation of mTDT 16 to guarantee that it asymptotically follows an exact 2 kÀ1 under the null hypothesis of no linkage À À À, mTDT 1 and 2G. We have chosen these tests because they have shown to be powerful tests with computational complexity lineal to the number of founders and the number of SNPs. As an example, mTDT S , the slowest one, has upper bound time complexity Oðmðn þ k 2 ÞÞ, m being the number of windows being analyzed, n the sample size and k the number of di®erent haplotypes in a window, with k ( n even for windows of several consecutive markers due to linkage disequilibrium. Therefore they are a®ordable to be used as tests to detect risk variants in GWASs. Other tests, such as the Length Contrast Test, 9 or the Signed Rank Test 9 have less power under a wide range of scenarios and have computational complexity quadratic on the number of founders. 15 By using simulations we¯rst have shown that 2GTree is robust to population structure and admixture. Thus, Table 4 shows that type-I error rates are very close to the nominal value used to reject the null hypothesis under di®erent scenarios used to simulate population structure and admixture.
Once we have shown the test has the correct behavior under the null hypothesis of no linkage, even in the case of population structure and admixture, we have compared association rates between the state-of-the-art multimarker TDTs under a wide range of scenarios. Figure 3 shows results for haplotypes of length 20 and two disease susceptibility loci under the additive, dominant-and-dominant and recessive-orrecessive genetic models and nominal level ¼ 0:05. Results for all the other congurations can be seen in Figs. S1 to S15 at the supplementary web site. As it can be observed in all the plots, 2GTree usually has the highest association rates at ¼ 0 i.e. the highest sensitivity rates (power), followed by 2G. Moreover, the test is also locusspeci¯c, so that association rates experience a strong decay when recombination factor increases. This means that 2GTree will discriminate better between causal variants and those in linkage disequilibrium with them. Overall, and focusing on haplotypes of width 20 to make di®erences more clear, 2GTree outperforms in power (average sensitivity values from 100 data sets) 31 out of the 45 di®erent scenarios all the other algorithms, 2G outperforms 8 out of 45 the other algorithms, TDT 1 only wins once (one-locus recessive model at relative risk 1:2) and 2G and 2GTree have 5 ties out of those 45 scenarios (see Table 5 ).
The same pattern can be seen when using real data sets. Figure 4 shows power results in sliding window maps (window size 15 and o®set 1) for IL7R (a) and IL2R (b) locus, respectively. It is interesting to note that (1) 2GTree reaches the highest association at the windows with the highest y-axis values, i.e. windows containing truly risk markers or markers in strong linkage disequilibrium with them (windows on the left in these plots) and (2) in other windows, i.e. windows that may show some degree of association just because of some extent of linkage disequilibrium, 2GTree is usually more monotonic and not the one with the highest association values. These results may respectively indicate that the test is (1) more powerful than the others and (2) more locus-speci¯c as well. Figures S16 to S21 at the supplementary web site Note: Table cells show the number of times an algorithm has the largest power among all the algorithms used. All the scenarios above referred have been considered. Results are displayed by genetic models: one disease locus (column two), two disease loci A (additive, dominant-or-dominant and recessive-or-recessive genetic models) (column three) and two disease susceptibility loci B (dominant-and-dominant, threshold and modi¯ed genetic models) (column four).
show sliding windows for power and speci¯city results for all the data sets used.
Figures S22 to S27 use comparative TDT (CTDT) maps 29 instead. We have also shown that 2GTree is computationally a®ordable as a genome-wide association test, as it has lineal complexity to the number of positions to be analyzed, m, and the sample size n, with upper bound Oðmðn þ k 2 ÞÞ. As k < < n even for haplotype windows of several markers due to linkage disequilibrium, we can simplify its complexity in terms of m and n to be OðmnÞ.
Conclusion
We have introduced a Bayesian approach to improve 2G, 15 an algorithm to select loci in association with a disease by analyzing the genome of a set of nuclear families, a®ected o®spring and their parents. The 2G algorithm is a very simple, e±cient and highly reproducible multimarker Transmission/Disequilibrium method. Its simplicity is the cause of its high reproducibility, as it classi¯es haplotypes into only two groups: high-and low-risk haplotypes. However, power may decrease in presence of rare haplotypes. The measure presented in this work, 2GTree, uses a Bayesian approach so that prior knowledge is introduced in order to estimate the probability for an haplotype to be low or high risk. The prior knowledge is based on haplotype similarity, by assuming that the more similar the haplotypes are among them, the more recent their common ancestor is. Moreover, those haplotypes with more certainty about the group they belong to are the ones used to decide about the prior knowledge for those with higher uncertainty.
Simulation and real studies have shown that 2GTree usually reaches the same power as 2G does and many times it outperforms 2G. Those situations where power does not increase compared with 2G or it is sightly lower, may correspond to a wrong prior assumption. However, consequences in the¯nal posterior distribution are small and power keeps very close to the one obtained by 2G.
We believe the proposed algorithm may be very helpful in genome-wide association studies. Although 2G and 2GTree converge with sample size, for small samples 2GTree may make a di®erence and help to discover causal variants in complex diseases. It may be especially important with the¯rst data sets genotyped by using the next-generation sequencing technology, as the number of genotyped individuals may be small. The 2G technique is crucial as a method to choose and reduce the number of input variables when building genome-wide predictors of individual risk to complex diseases. 30, 31 The improvement of 2GTree may be very important as well to increase the overall accuracy of these genetic predictors.
Web resources
A supplementary website has been created for this work at http://bios.ugr.es/ 2GTree, where Figs. S1ÀS27, the real data sets used, the software trioSample 11 implemented to obtain the samples upon which simulations were performed (scripts for linux and software in c++) and 2GTree, the software used to implement the method, are available.
